Mutations in PRKCSH Cause Isolated Autosomal Dominant Polycystic Liver Disease
Open accessThe DOI matches its Crossref record; 40 of the 42 references it cites were found in a registry or an index.
Abstract
Autosomal dominant polycystic liver disease (ADPLD) is a distinct clinical and genetic entity that can occur independently from autosomal dominant polycystic kidney disease (ADPKD). We previously studied two large kindreds and reported localization of a gene for ADPLD to an approximately 8-Mb region, flanked by markers D19S586/D19S583 and D19S593/D19S579, on chromosome 19p13.2-13.1. Expansion of these kindreds and identification of an additional family allowed us to define flanking markers CA267 and CA048 in an approximately 3-Mb region containing >70 candidate genes. We used a combination of denaturing high-performance liquid chromatography (DHPLC) heteroduplex analysis and direct sequencing to screen a panel of 15 unrelated affected individuals for mutations in genes from this interval. We found sequence variations in a known gene, PRKCSH, that were not observed in control individuals, that segregated with the disease haplotype, and that were predicted to be chain-terminating mutations. In contrast to PKD1, PKD2, and PKHD1, PRKCSH encodes a previously described human protein termed "protein kinase C substrate 80K-H" or "noncatalytic beta-subunit of glucosidase II." This protein is highly conserved, is expressed in all tissues tested, and contains a leader sequence, an LDLa domain, two EF-hand domains, and a conserved C-terminal HDEL sequence. Its function may be dependent on calcium binding, and its putative actions include the regulation of N-glycosylation of proteins and signal transduction via fibroblast growth-factor receptor. In light of the focal nature of liver cysts in ADPLD, the apparent loss-of-function mutations in PRKCSH, and the two-hit mechanism operational in dominant polycystic kidney disease, ADPLD may also occur by a two-hit mechanism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, Glucosidase II is involved in human polycystic disease [8,9,10] and finally in the demyelinating ones of the central nervous system (CNS), according to the latest evidence [11].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [9]
Citations
Cites
Setting the Standards: Quality Control in the Secretory Pathway
Ellgaard, L., Molinari, M., & Helenius, A. (1999) · Science · doi:10.1126/science.286.5446.1882 · Cited by 1,192
Harris, P. C., & Torres, V. E. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.101707.125712 · Cited by 801
Self-citationSomatic Inactivation of Pkd2 Results in Polycystic Kidney Disease
Wu, G., D'Agati, V., Cai, Y., Markowitz, G., Park, J. H., Reynolds, D. M., Maeda, Y., Le, T. C., Hou, H., Kucherlapati, R., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81570-6 · Cited by 570 · cited 2×
“The latter region was excluded from mutation detection, because we hypothesized that—as is the case with ADPKD (Wu et al. 1998)—the liver cystic pathway in ADPLD will be conserved in mice.”
BackgroundSelf-citationRavine, D., Sheffield, L., Danks, D. M., Gibson, R. N., Walker, R. G., & Kincaid-Smith, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92026-5 · Cited by 564 · cited 11×
“The latter region was excluded from mutation detection, because we hypothesized that—as is the case with ADPKD (Wu et al. 1998)—the liver cystic pathway in ADPLD will be conserved in mice.”
BackgroundInfluentialPazour, G. J., San Agustin, J. T., Follit, J. A., Rosenbaum, J. L., & Witman, G. B. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00877-1 · Cited by 531 · cited 2×
“1999) and only selectively trafficked to the primary cilia (Pazour et al. 2002).”
BackgroundOnuchic, L. F., Furu, L., Nagasawa, Y., Hou, X., Eggermann, T., Ren, Z., Bergmann, C., Senderek, J., Esquivel, E., Zeltner, R., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/340448 · Cited by 508 · cited 1×
“A 386-bp RT-PCR product from exons 10–13 of PRKCSH was 32P-labeled using the multiprime method and was hybridized to an adult human MTN blot (Clontech), as described elsewhere (Onuchic et al. 2002).”
MethodSelf-citationNiehues, R., Hasilik, M., Alton, G., Körner, C., Schiebe-Sukumar, M., Koch, H. G., Zimmer, K. P., Wu, R., Harms, E., Reiter, K., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2350 · Cited by 422 · cited 2×
“Interestingly, autosomal recessive carbohydratedeficient glycoprotein syndrome type Ib is associated with congenital hepatic fibrosis and results from nearly complete absence of phosphomannose isomerase, the enzyme needed to maintain the dolichol pyrophosphateoligosaccharide pool (Jaeken et al. 1998; Niehues et al. 19…”
BackgroundThornalley, P. J. (1998) · PubMed · Cited by 387
Identification and Characterization of Polycystin-2, thePKD2 Gene Product
Cai, Y., Maeda, Y., Cedzich, A., Torres, V. E., Wu, G., Hayashi, T., Mochizuki, T., Park, J. H., Witzgall, R., & Somlo, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28557 · Cited by 364 · cited 1×
“It has been suggested that the polycystin-1/2 complex forms in the ER (Newby et al. 2002) and polycystin-2 is largely retained in the ER membrane (Cai et al. 1999) and only selectively trafficked to the primary cilia (Pazour et al. 2002).”
BackgroundSelf-citationLi, Y. M., Mitsuhashi, T., Wojciechowicz, D., Shimizu, N., Li, J., Stitt, A., He, C., Banerjee, D., & Vlassara, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11047 · Cited by 341 · cited 2×
“Although 80K-H turned out to be a poor substrate for PKC, other possible functions were later suggested by its ability to bind advanced glycation end products (Li et al. 1996; Thornalley 1998) and by its rapid phosphorylation following activation of fibroblast growth-factor receptors (Shaoul et al.”
Background
Cited by
Items 101–192 of 192
Molecular genetics of renal ciliopathies
Barroso‐Gil, M., Olinger, E. G., & Sayer, J. A. (2021) · Biochemical Society Transactions · doi:10.1042/bst20200791 · Cited by 25
Regulated ion transport in mouse liver cyst epithelial cells
Doctor, R. B., Johnson, S. M., Brodsky, K. S., Amura, C. R., Gattone, V. H., & Fitz, J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.11.006 · Cited by 24
Murine models of polycystic kidney disease
Menezes, L. F., & Germino, G. G. (2013) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2013.10.002 · Cited by 24
“Caused by mutations in PRKCSH or SEC63, isolated ADPLD is characterized by an ADPKD-like liver phenotype without kidney cysts [50,51].”
BackgroundAn update on ductal plate malformations and fibropolycystic diseases of the liver
Mirza, H., Besse, W., Somlo, S., Weinreb, J. C., Kenney, B. C., & Jain, D. (2022) · Human Pathology · doi:10.1016/j.humpath.2022.06.022 · Cited by 25
Self-citationProfiling celiac disease antibody repertoire
D’Angelo, S., Mignone, F., Deantonio, C., Niro, R. D., Bordoni, R., Marzari, R., Bellis, G. D., Not, T., Ferrara, F., Bradbury, A. M., et al. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.04.009 · Cited by 21
Mutation of sec63 in zebrafish causes defects in myelinated axons and liver pathology
Monk, K. R., Voas, M. G., Franzini‐Armstrong, C., Hakkinen, I., & Talbot, W. S. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.009217 · Cited by 29
Satoh, T., Toshimori, T., Noda, M., Uchiyama, S., & Kato, K. (2016) · Protein Science · doi:10.1002/pro.3031 · Cited by 23
Cystic diseases of the kidneys
Hogan, M. C., & Torres, V. E. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-3362-2.00053-1 · Cited by 20
Self-citationDesmet, V. J. (2005) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(05)86360-2 · Cited by 20
“Elle résulte d’un autre type de mutation (gène PRKCSH sur le chromosome 19) [26, 27].”
BackgroundDe Masi, R., & Orlando, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137373 · Cited by 20
Khaodee, W., Inboot, N., Udomsom, S., Kumsaiyai, W., & Cressey, R. (2017) · Cellular Oncology · doi:10.1007/s13402-017-0349-1 · Cited by 16
PKD2 mutations in a Czech population with autosomal dominant polycystic kidney disease
Štekrová, J., Reiterová, J., Merta, M., Damborský, J., Židovská, J., Kebrdlová, V., & Kohoutová, M. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh083 · Cited by 16
“b-subunit of glucosidase II), have been identified as causes of autosomal dominant polycystic liver disease in three large, independent families [2].”
BackgroundHousset, C. (2005) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(05)86361-4 · Cited by 20
“Neuf mutations de PRKCSH ont été décrites à ce jour [12, 13, 15].”
Pompili, M., Ardito, F., Brunetti, E., Cabibbo, G., Calliada, F., Cillo, U., de Sio, I., Golfieri, R., Grova, M., Gruttadauria, S., et al. (2022) · Digestive and Liver Disease · doi:10.1016/j.dld.2022.08.030 · Cited by 15
Renal ciliopathies: promising drug targets and prospects for clinical trials
Devlin, L. A., Sudhindar, P. D., & Sayer, J. A. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2218616 · Cited by 19
Roy, K., & Marin, E. P. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4224-6 · Cited by 15
Developmental and Inherited Liver Disease
Quaglia, A., Roberts, E. A., & Torbenson, M. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6697-9.00003-0 · Cited by 20
“This protein, now renamed hepatocystin, seems to segregate in families with PCLD. 490, 491 The protein is widely distributed in tissues and predicted to be an endoplasmic reticulum luminal protein that recycles from the Golgi complex.”
Song, J., Ngo, L., Bell, K., & Zheng, Y. G. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.1c00935 · Cited by 12
Maladies kystiques du foie. Génétique et biologie cellulaire.
Housset, C. (2005) · Gastroentérologie Clinique et Biologique · Cited by 12
Folding and Quality Control of Glycoproteins
Suzuki, T., Tanabe, K., & Funakoshi, Y. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00046-5 · Cited by 12
Expanding the variability of the ADPKD-GANAB clinical phenotype in a family of Italian ancestry
Delbarba, E., Econimo, L., Dordoni, C., Martin, E., Mazza, C., Savoldi, G., Alberici, F., Scolari, F., & Izzi, C. (2021) · Journal of Nephrology · doi:10.1007/s40620-021-01131-w · Cited by 12
Peces, R. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i48.7690 · Cited by 11
“In 2003, two independent groups demonstrated that mutations in PRKCSH, encoding the β-subunit of glucosidase II, a N-linked glycanprocessing enzyme in the endoplasmic reticulum, cause isolated ADPLD [5, 6 ]”
BackgroundManagement of Polycystic Liver Disease
Cheung, J. K., Scudamore, C. H., & Yoshida, E. M. (2004) · Canadian Journal of Gastroenterology · doi:10.1155/2004/947345 · Cited by 11
Association of a novel PKHD1 mutation in a family with autosomal dominant polycystic liver disease
Wang, J., Yang, H., Guo, R., Sang, X., & Mao, Y. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-3318 · Cited by 12
“Detection of mutations in patients with ADPLD ADPLD is a rare autosomal dominant disease with an incidence of 1/100,000 (1), which is driven by mutations in at least seven genes, including PRKCSH (6,7), SEC63 (8), GANAB (9), SEC61B (9), ALG8 (9), LRP5 (10), and PKHD1 (9).”
BackgroundResultInfluentialLiver Involvement in Congenital Disorders of Glycosylation: A Systematic Review
Colantuono, R., D’Acunto, E., Melis, D., Vajro, P., Freeze, H. H., & Mandato, C. (2021) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003209 · Cited by 12
A SEC61A1 variant is associated with autosomal dominant polycystic liver disease
Schlevogt, B., Schlieper, V., Krader, J., Schröter, R., Wagner, T., Weiand, M., Zibert, A., Schmidt, H., Bergmann, C., Nedvetsky, P. I., et al. (2022) · Liver International · doi:10.1111/liv.15493 · Cited by 10
Structural Aspects of ER Glycoprotein Quality-Control System Mediated by Glucose Tagging
Satoh, T., & Kato, K. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-2158-0_8 · Cited by 11
Desmet, V. J., & Roskams, T. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511547409.006 · Cited by 9
Schönauer, R. A.-R., Sierks, D., Boerrigter, M. M., Jawaid, T., Caroff, L., Audrézet, M., Friedrich, A., Shaw, M. M., Degenhardt, J., Forberger, M., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.12.007 · Cited by 10
Self-citationMolecular Mechanisms of Isolated Polycystic Liver Diseases
Yu, Z., Shen, X., Hu, C., Zeng, J., Wang, A., & Chen, J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.846877 · Cited by 9
“The linkage between PRKCSH and PCLD was established in 2000 and 2003 (Li et al., 2003; Reynolds et al., 2000).”
BackgroundRoy, S. G., Li, Z., Guo, Z., Long, K. T., Rehrl, S., Tian, X., Dong, K., & Besse, W. (2023) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000164 · Cited by 9
Self-citationProcessing of Protein-Bound N-Glycans
Schachter, H. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00034-9 · Cited by 10
Ding, F., Tang, H., Zhao, H., Feng, X., Yang, Y., Chen, G., Chen, W., & Xu, C. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7449 · Cited by 9
Brûlé, S., Sayasith, K., Sirois, J., Silversides, D. W., & Lussier, J. G. (2006) · Gene · doi:10.1016/j.gene.2006.12.012 · Cited by 9
Devlin, L. A., Dewhurst, R. M., Sudhindar, P. D., & Sayer, J. A. (2025) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2025.01.009 · Cited by 8
Bisceglie, A. M. D., & Befeler, A. S. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00094-9 · Cited by 8
Hepatocystin is Essential for TRPM7 Function During Early Embryogenesis
Overton, J. D., Komiya, Y., Mezzacappa, C., Nama, K., Cai, N., Lou, L., Fedeles, S. V., Habas, R., & Runnels, L. W. (2015) · Scientific Reports · doi:10.1038/srep18395 · Cited by 8
Somlo, S., & Guay‐Woodford, L. M. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-449851-8.00024-3 · Cited by 9
Self-citationHepatocystin Is Not Secreted in Cyst Fluid of Hepatocystin Mutant Polycystic Liver Patients
Waanders, E., Lameris, A. L. L., den Camp, H. J. M. O., Pluk, W., Gloerich, J., Strijk, S. P., & Drenth, J. P. H. (2008) · Journal of Proteome Research · doi:10.1021/pr8000282 · Cited by 7
Minimally invasive management of dysontogenetic hepatic cysts
Kornprat, P., Cerwenka, H., Bacher, H., El-Shabrawi, A., Tillich, M., Langner, C., & Mischinger, H. (2004) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-004-0506-7 · Cited by 6
“Liver cysts will be found in 25%–35% of patients with PKD [17, 18].”
BackgroundRajoriya, N., Tripathi, D., Leithead, J., Gunson, B. K., Lord, S., Ferguson, J., & Hirschfield, G. M. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i45.9966 · Cited by 7
Torres, V. E., & Grantham, J. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10045-4 · Cited by 12
Self-citationThe in silico characterization of neutral alpha-glucosidase C (GANC) and its evolution from GANAB
Gabriško, M. (2019) · Gene · doi:10.1016/j.gene.2019.144192 · Cited by 5
Folding and Quality Control of Glycoproteins
Suzuki, T., & Fujihira, H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.14947-9 · Cited by 6
Developmental and Inherited Liver Disease
Quaglia, A., Roberts, E. A., & Torbenson, M. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8228-3.00003-x · Cited by 6
Ruchelli, E. D. (2004) · Springer eBooks · doi:10.1007/978-1-4419-9066-2_8 · Cited by 5
Autosomal Dominant Polycystic Kidney Disease and Inherited Cystic Diseases
Somlo, S., Torres, V. E., & Caplan, M. J. (2008) · Elsevier eBooks · doi:10.1016/b978-012088488-9.50084-x · Cited by 6
Self-citationCongenital Disorders of Glycosylation
Sosicka, P., Ng, B. G., & Freeze, H. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819475-1.00013-4 · Cited by 5
Mannose-6-Phosphate Receptor Homologous Protein Family
Gupta, G. (2012) · Springer eBooks · doi:10.1007/978-3-7091-1065-2_5 · Cited by 4
PRKCSH Genetic Mutation Was Not Found in Taiwanese Patients with Polycystic Liver Disease
Yang, A., Shih, S., Chu, C., Wang, T.-E., & Yang, W. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0776-6 · Cited by 4
“Through the expansion of the families in the linkage study, Li et al. [ 5 ] narrowed the candidate chromosome segment and reported that a mutation in PRKCSH gene may be responsible for PCLD.”
BackgroundMethodInfluentialDagmura, H., Daldal, E., Akbaş, A., Daşıran, F., & Okan, İ. (2019) · Journal of Surgical Case Reports · doi:10.1093/jscr/rjz014 · Cited by 4
“Two mutations have been found to cause this disorder: a mutation in the PRKCSH gene that encodes a protein called hepatocystin [8], and a mutation in the SEC63 gene that encodes for a component of the protein translocation machinery in the endoplasmic reticulum [9].”
BackgroundAutosomal Dominant Polycystic Kidney Disease
Somlo, S., Torres, V. E., & Caplan, M. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00080-x · Cited by 4
Self-citationEllis, J. L., Evason, K. J., Zhang, C., Fourman, M. N., Liu, J., Ninov, N., Delous, M., Vanhollebeke, B., Fiddes, I. T., Otis, J. P., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.2038 · Cited by 4
“…have been connected to mutations in genes including Protein Kinase C Substrate 80K-H (PRKCSH), SEC63, LDL receptor Related Protein 5 (LRP5), SEC61B, α-1,3-Glucosyltransferases ALG8, and ALG9 (Besse et al., 2019; Besse et al., 2017; Cnossen et al., 2014; Davila et al., 2004; Li et al., 2003a).”
BackgroundCao, H. S. T., Marcal, L. P., Mason, M. C., Yedururi, S., Joechle, K., Wei, S. H., & Vauthey, J. (2019) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2019.05.002 · Cited by 5
Combined Liver-Kidney Transplantation
Sanchez, E. Q., & Klintmalm, G. B. G. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-0118-2.50059-8 · Cited by 4
Severe Polycystic Liver Disease Is Not Caused by Large Deletions of the PRKCSH Gene
Cnossen, W. R., Maurits, J. S. F., Salomon, J., Morsche, R. H. M. T., Waanders, E., & Drenth, J. P. H. (2015) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21875 · Cited by 3
Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease
Boerrigter, M. M., Duijzer, R., Morsche, R. H. M. T., & Drenth, J. P. H. (2023) · Genes · doi:10.3390/genes14091755 · Cited by 6
Somatic Hits in Polycystic Liver Diseases
Cnossen, W. R. (2014) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.1000154 · Cited by 4
“About ~25% of PCLD patients carry a bonafide gene mutation in the PRKCSH gene or SEC63 gene [7-10].”
Fibrocystic Diseases of the Liver
Drenth, J. P. H., Bañales, J. M., Devaraj, K. M., Helmke, S. M., & Everson, G. T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00064-1 · Cited by 3
Advances in genetic, epigenetic and environmental aspects of rare liver diseases
Andersson, E. R., & Lohse, A. W. (2021) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2021.104411 · Cited by 3
Autosomal Dominant Polycystic Liver Disease
Qian, Q., Torres, V. E., & Somlo, S. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-524-8_16 · Cited by 2
Self-citationThe TRPP Signaling Module: TRPP2/Polycystin-1 and TRPP2/PKD1L1
Hofherr, A. (2012) · Methods in pharmacology and toxicology · doi:10.1007/978-1-62703-077-9_10 · Cited by 2
Germino, G. G., & Guay‐Woodford, L. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411602-3.00040-8 · Cited by 6
Fibrocystic Diseases of the Liver
Doctor, R. B., Smith, M. L., Fortune, B. E., Helmke, S. M., & Everson, G. T. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00067-x · Cited by 2
Germino, G. G., & Guay‐Woodford, L. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815876-0.00048-6 · Cited by 2
Rhodes, P. S., & Aranda, S. (2004) · Journal of diagnostic medical sonography · doi:10.1177/8756479304265038 · Cited by 2
“1.(5) Therefore, it is known that PLD can exist as a separate entity from ADPKD.”
BackgroundLee, W., Cheng, B., Lee, C., & Liao, S. (2024) · Journal of Medical Ultrasound · doi:10.4103/jmu.jmu_77_23 · Cited by 2
“[7,20,21] ADPKD caused by mutations in PRKCSH or LRP5 was also in a milder form [Figure 1 ].”
BackgroundBhuva, M., Thompson, E., Watson, C. M., Sava, F., & Griffiths, W. J. (2026) · Digestive Diseases and Sciences · doi:10.1007/s10620-026-10072-y · Cited by 1
Tratamiento quirúrgico de la enfermedad poliquística hepática autosómica dominante, serie de casos
Ayala, A. V., Aguilar, J. C., Jiménez, F., & Serpa, F. (2015) · Revista Colombiana de Cirugía · doi:10.30944/20117582.330 · Cited by 1
Glucosidase, Alpha Neutral AB; Glucosidase II Subunit Beta (GANAB, PRKCSH, α-Glucosidase II)
Nairn, A. V., & Moremen, K. W. (2014) · Springer eBooks · doi:10.1007/978-4-431-54240-7_140 · Cited by 2
Gall, É. C.-L., & Harris, P. C. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7784-0_1 · Cited by 1
Genetics of Fibrocystic Diseases of the Liver and Molecular Approaches to Therapy
Tuchman, M., Gahl, W. A., & Gunay‐Aygun, M. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-524-8_4 · Cited by 1
Análisis clínico y genético (PKD2) de la Poliquistosis renal autosómica dominante
Gómez, M. P. F. (2008) · Gredos (University of Salamanca) · doi:10.14201/gredos.22489 · Cited by 1
Bile Duct Development and Biliary Differentiation
Lemaigre, F. P. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-7107-4_15 · Cited by 2
Benign Tumors, Nodules, and Cystic Diseases of the Liver
Bisceglie, A. M. D., & Befeler, A. S. (2011) · Wiley eBooks · doi:10.1002/9781119950509.ch35
Ampuero, J., Bañales, J. M., Soriano, G., Crespo, J., Olcoz, J. L., Moisés Diago, M., Calleja, J. L., & Romero‐Gómez, M. (2014) · PubMed
Ampuero, J., Bañales, J. M., Soriano, G., Crespo, J., Olcoz, J. L., Moisés Diago, M., Calleja, J. L., & Romero‐Gómez, M. (2014) · idUS (Universidad de Sevilla)
Screening analysis of candidate gene mutations in a kindred with polycystic liver disease
Jin, S. H. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i8.2343
Boonzaaier-Botha, H., & Cock, C. (2004) · South African Journal of Radiology · doi:10.4102/sajr.v8i2.132
Response to Palmirotta et al.: The frequency of the PRKCSH GAG trinucleotide repeat in PCLD patients
Waanders, E., Janssen, M. J., & Drenth, J. P. H. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01537.x
“In the course of our studies we detected the DIP variant in the glutamic acid stretch in exon 11 of PRKCSH, but did not report them because these variants are thought to be benign polymorphisms (2).”
BackgroundCysts and Polycystic Liver Disease
Giuliani, A., Aloia, S., Crolla, E., Sodano, L., Rocca, A., & Calise, F. (2015) · Springer eBooks · doi:10.1007/978-3-319-12985-3_8
Protein Quality Control in the Endoplasmic Reticulum
Okuda-Shimizu, Y., Shen, Y., & Hendershot, L. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00294-1
Benign Tumors, Nodules, and Cystic Diseases of the Liver
Caldéraro, J., & Zucman‐Rossi, J. (2017) · Wiley eBooks · doi:10.1002/9781119251316.ch35
Fierbinteanu-Braticevici, C. G., & Moldoveanu, A. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-24432-3_20
Fibrocystic Diseases of the Liver
Doctor, R. B., Nash, S. R., Nichols, M. T., & Everson, G. T. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-3258-8.50075-9
Scaife, C. L. (2008) · Springer eBooks · doi:10.1007/978-0-387-68113-9_49
Deng, Q., Liu, F., He, M., Ou, Y., & Zhang, L. (2022) · International Journal of Surgery Open · doi:10.1016/j.ijso.2022.100517
Isolated polycystic liver disease in a child
Irene, M., & Sakulen, H. (2023) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2023.108950
“Li and Davila et al. demonstrated that isolated PCLD can be caused by mutations of genes involving PRKCSH and SEC63 on chromosome 19 and 6 respectively [8,9].”
BackgroundGenetic Analysis of Severe Polycystic Liver Disease in Japan
Mizuno, H., Besse, W., Sekine, A., Long, K. T., Kurihara, S., Oba, Y., Yamanouchi, M., Hasegawa, E., Suwabe, T., Sawa, N., et al. (2024) · Kidney360 · doi:10.34067/kid.0000000000000461 · Cited by 1
Self-citationPatterson, M. C., Ng, B. G., & Eklund, E. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-10944-7.00062-7
Renal Cystic Disease in the Elderly
Torrá, R. (2007) · Springer eBooks · doi:10.1007/978-0-387-72659-5_19
Exome sequencing in patients with medullary sponge kidney
Tournebize, C., Robert, T., Abid, N., Mul, A. D., Schleef, M., LeFEVRE, F. A., Dubourg, L. D., Dancer, M. S., Letavernier, E., & Lemoine, S. (2026) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfag043
Metadata
- Authors
- Li, A., Davila, S., Furu, L., Qian, Q., Tian, X., Kamath, P. S., King, B. F., Torres, V. E., & Somlo, S.
- Affiliations
- Yale University (US)
- Mayo Clinic (US)
- Corresponding author
- Somlo, Stefan
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 72
- Issue
- 3
- Pages
- 691-703
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1180260
- OpenAlex
- W2111226757
- Cited by
- 193
- References
- 42
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 7 · 2022: 10 · 2021: 8 · 2020: 8 · 2019: 9 · 2018: 8 · 2017: 7 · 2016: 3 · 2015: 10 · 2014: 13 · 2013: 6 · 2012: 10
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3793 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (P50DK057328, T32-DK07356, R01DK051041, P50DK57328, DK51041, T32DK007356)
- National Center for Research Resources (M01-RR00 585, M01RR000585)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Keywords
- autosomal dominant polycystic liver disease, PRKCSH, loss-of-function mutations, two-hit mechanism, haplotype mapping, N-glycosylation, fibroblast growth factor receptor signaling, autosomal dominant polycystic kidney disease
- MeSH terms
- Myristoylated Alanine-Rich C Kinase Substrate, Amino Acid Sequence, Base Sequence, Calcium-Binding Proteins, Chromosome Mapping, Chromosomes, Human, Pair 19, Cysts, DNA, Female, Genes, Dominant, Genetic Markers, Glucosidases, Haplotypes, Humans, Genetic Linkage, Liver Diseases, Male, Membrane Proteins, Molecular Sequence Data, Mutation, Pedigree, Phosphoproteins, Protein Kinase C, Sequence Alignment, Polycystic Kidney, Autosomal Dominant, Point Mutation, Sequence Homology, Amino Acid, Alternative Splicing, Amino Acid Substitution, Reverse Transcriptase Polymerase Chain Reaction, Intracellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.